2022
DOI: 10.1016/j.eururo.2021.10.017
|View full text |Cite
|
Sign up to set email alerts
|

Description of Surgical Technique and Oncologic and Functional Outcomes of the Precision Prostatectomy Procedure (IDEAL Stage 1–2b Study)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
10
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
2

Relationship

3
4

Authors

Journals

citations
Cited by 21 publications
(10 citation statements)
references
References 63 publications
0
10
0
Order By: Relevance
“…5 Fortunately however, it is amenable to mitigation. Several anatomic mechanisms of early continence recovery have been investigated over the years including preservation of the membranous urethral length, [22][23][24] the bladder neck, 25,26 the detrusor apron, 27 the anterior pelvic support structures contained within the space of Retzius, 28,29 the prostatic capsule 30,31 and the neural tissue, 32,33 and reconstruction of the anterior and posterior musculofascial structures. [17][18][19][20][21] The existing RARP approaches employ a host of these aforementioned technical refinements in varying permutation-combinations to hasten the recovery of urinary control while maintaining oncologic equipoise coupled with technical ease.…”
Section: Discussionmentioning
confidence: 99%
“…5 Fortunately however, it is amenable to mitigation. Several anatomic mechanisms of early continence recovery have been investigated over the years including preservation of the membranous urethral length, [22][23][24] the bladder neck, 25,26 the detrusor apron, 27 the anterior pelvic support structures contained within the space of Retzius, 28,29 the prostatic capsule 30,31 and the neural tissue, 32,33 and reconstruction of the anterior and posterior musculofascial structures. [17][18][19][20][21] The existing RARP approaches employ a host of these aforementioned technical refinements in varying permutation-combinations to hasten the recovery of urinary control while maintaining oncologic equipoise coupled with technical ease.…”
Section: Discussionmentioning
confidence: 99%
“…Despite improved surgical techniques, concerns for urinary incontinence and erectile dysfunction persist both in patients and provider, prompting many to pursue alternative management strategies such as active surveillance and focal therapy that are associated with a more favorable side-effect profile. Recently, Dr. Mani Menon developed the Precision Prostatectomy (MPP), a new organ-preserving surgical approach for the management of low to intermediate-risk prostate cancer ( 48 , 49 ). The MPP involves subtotal resection of the prostate with a radical excision on the side of the index lesion while a thin 5–10 mm rim of tissue, including the prostatic capsule and seminal vesicle, is deliberately preserved on the contralateral side with less cancer burden.…”
Section: Discussionmentioning
confidence: 99%
“…This procedure is intended for patients with favorable risk prostate cancer who are pre-operatively potent, and are willing to follow an active surveillance protocol post-operatively. Early results are promising with 85% of all-comers and 90% of the pre-operatively potent men being potent at 12 months, with rates of residual cancer and need for secondary procedures appear to be equivalent or superior to those of who undergo high-intensity focused ultrasound (HIFU) ( 48 ). The precision prostatectomy offers a favorable cancer control compared to less invasive focal therapy techniques, and minimizes the risk of overtreatment associated with whole gland treatments such as radiation or radical prostatectomy.…”
Section: Discussionmentioning
confidence: 99%
“…Although there is some PSA-producing prostate tissue in situ, the median PSA at 24 months was 0.0 IQR (0.0–0.3) in the first 88 patients. 17 Thus, we believe that the AUA definition is stringent but appropriate; as the data matures, the biopsy criteria may evolve as patients with stable but elevated PSA may not need a biopsy. Nevertheless, it is critical to be able to adequately sample the prostatic remnant to discern a benign PSA elevation from one due to cancer.…”
Section: Discussionmentioning
confidence: 99%
“…We have previously reported the highly favorable results of 88 patients who underwent this novel procedure. 17 Notably, by 12 months postoperatively, 90% of preoperatively potent men reported a return of erections sufficient for intercourse. Furthermore, at 36 months of follow-up, only 7% of patients were found to harbour clinically significant prostate cancer in their remnant prostate tissue, far less than the historical outcomes with focal ablative therapies.…”
Section: Introductionmentioning
confidence: 99%